EIN
Showing 1 - 25 of 412
Abdominoplasty Trial in Jerusalem (Lactated Ringer's Fluid Bolus Response to Low Urinary Output, Post-Anesthesia Care Unit
Recruiting
- Abdominoplasty
- Lactated Ringer's Fluid Bolus Response to Low Urinary Output
- Post-Anesthesia Care Unit Lactated Ringer's Fluid Management Protocol
-
Jerusalem, IsraelHadassah Ein-Carem Medical Center
Jul 11, 2023
Endometrial Carcinoma, Obesity, EIN Trial in Boston (CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral)
Recruiting
- Endometrial Carcinoma
- +4 more
- CONCURRENT LAPAROSCOPIC HYSTERECTOMY AND WEIGHT LOSS SURGERY-Referral
-
Boston, Massachusetts
- +1 more
Aug 2, 2022
Derivation of Induced Pluripotent Stem Cells FromExisting
Recruiting
- Amyotrophic Lateral Sclerosis
-
Jerusalem, Israel
- +1 more
Feb 13, 2022
Acute Decompensated Heart Failure, Cytokine Storm, Inflammatory Response Trial in Jerusalem (Copaxone, guideline directed
Completed
- Acute Decompensated Heart Failure
- +3 more
- Copaxone
- guideline directed medical therapy (GDMT)
-
Jerusalem, IsraelHadassah Ein Kerem medical center-hospital ,Cardiology Departmen
Aug 15, 2023
Early Warning of Intradialytic Hypotension in Hemodialysis
Completed
- Hypotension of Hemodialysis
- Continuous monitoring
-
Jerusalem, IsraelThe Hadassah Ein Kerem Medical Center
Jul 19, 2022
Novel Algorithm System for Polypharmacy Patient Medication
Completed
- Polypharmacy Patients
- Multi-drug analysis of polypharmacy treatment
-
Jerusalem, IsraelHadassah Ein Kerem
Oct 18, 2022
Obese, Quality of Life, Exercise Trial in Jerusalem (Physical Activity counseling)
Active, not recruiting
- Obese
- +4 more
- Physical Activity counseling
-
Jerusalem, IsraelHadassah Ein Kerem Medical Center
May 12, 2022
Hypoparathyroidism Trial in Jerusalem (EBP05, Forteo 20 mg, EBP11)
Recruiting
- Hypoparathyroidism
- EBP05
- +4 more
-
Jerusalem, IsraelClinical Research Center Hadassah Ein Kerem Medical Center
Jul 27, 2023
Existing Fibroblast Cells to Convert to Induced Pluripotent Stem
Recruiting
- Pregnant, Healthy Females
- Healthy Male Newborns
-
Jerusalem, IsraelHadassah Ein Kerem
Feb 13, 2022
Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -
Completed
- Nonalcoholic Fatty Liver Disease
- Anti-human CCL24 monoclonal antibody (CM-101) - Part One
- +3 more
-
Jerusalem, IsraelHadassah University Hospital - Ein Kerem
Sep 13, 2023
Pericardial Access Trial in Jerusalem, Poznan, Warsaw (ViaOne device)
Recruiting
- Pericardial Access
- ViaOne device
-
Jerusalem, Israel
- +3 more
Mar 3, 2022
UsingWearable, Wireless, Non-invasive PPG-Based Device toSwan
Completed
- Cardiac Output, Low
- +2 more
- non-invasive monitoring
-
Jerusalem, IsraelThe Hadassah Ein Kerem Medical Center
Jul 19, 2022
Colorectal Tumors, Colorectal Cancer, Colonic Polyp Trial in Tabuk (Stool for Occult Blood Test and Colonoscopy with
Completed
- Colorectal Neoplasms
- +3 more
- Stool for Occult Blood Test and Colonoscopy with comprehensive medical checkups
-
Tabuk, Saudi ArabiaPublic Primary Health Care Centers in the Tabuk City
Dec 6, 2022
Nonalcoholic Steatohepatitis Trial in Israel (5 mg/kg CM-101, Placebo)
Completed
- Nonalcoholic Steatohepatitis
- 5 mg/kg CM-101
- Placebo
-
Be'er Sheva, Israel
- +8 more
Apr 11, 2023
Pain, Postoperative, Postoperative Nausea and Vomiting, Anxiety Trial in Jerusalem (Tetrahydrocannabinol, Dummy oromucosal)
Recruiting
- Pain, Postoperative
- +2 more
- Tetrahydrocannabinol
- Dummy oromucosal
-
Jerusalem, IsraelHasassah - Hebrew University Ein Kerem Medical Center
Mar 20, 2022
Prostate Cancer Trial in Kansas City (Flav-ein capsules, Placebo)
Terminated
- Prostate Cancer
- Flav-ein capsules
- Placebo
-
Kansas City, KansasUniversity of Kansas Medical Center
Feb 7, 2022
Skin Cancer, Mucosal Tumor of Oral Cavity, Soft Tissue Tumor Trial in Jerusalem (Radiation: Diffusing Alpha Radiation Emitters
Recruiting
- Skin Cancer
- +2 more
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
-
Jerusalem, IsraelSharett institute, Hadassah Medical Center - Ein-Kerem
Jun 14, 2022
Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Jerusalem (Radiation: Diffusing Alpha Radiation Emitters
Not yet recruiting
- Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT
-
Jerusalem, IsraelSharett institute, Hadassah University Hospital - Ein-Kerem
Jul 4, 2022
Skin Cancer, Mucosal Tumor of Oral Cavity, Soft Tissue Tumor Trial in Jerusalem (Radiation: Diffusing Alpha Radiation Emitters
Recruiting
- Skin Cancer
- +2 more
- Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
-
Jerusalem, IsraelSharett institute, Hadassah University Hospital - Ein-Kerem
Feb 16, 2022
Depression, Rumination - Thoughts Trial in Berlin (Adaptive emotional cognitive control training, Adaptive non-emotional feature
Completed
- Depression
- Rumination - Thoughts
- Adaptive emotional cognitive control training
- Adaptive non-emotional feature match task
-
Berlin, GermanyFreie Universität Berlin
Jul 27, 2022
Feeding Tube, Dysphagia Trial in Jerusalem (Fidmi enhanced enteral feeding device)
Suspended
- Feeding Tube
- Dysphagia
- Fidmi enhanced enteral feeding device
-
Jerusalem, Ein Kerem, Israel
- +1 more
Feb 6, 2022
Non-invasively Measured Parameters to Clinical Outcomes in CHF
Completed
- Congestive Heart Failure
- Short term monitoring
-
Jerusalem, IsraelThe Hadassah Ein Kerem Medical Center
Dec 9, 2021
Diabetic Foot Ulcer, Pseudomonas Aeruginosa Infection, Staphylococcus Aureus Infection Trial in Jerusalem, Tel Aviv (TP-102)
Recruiting
- Diabetic Foot Ulcer
- +3 more
- TP-102
-
Jerusalem, Israel
- +1 more
Jun 17, 2022
Covid19 Trial in Jerusalem (ALLOCETRA-OTS, Placebo)
Active, not recruiting
- Covid19
- ALLOCETRA-OTS
- Placebo
-
Jerusalem, IsraelHadassah Ein Kerem Medical Center
Aug 29, 2022